Clinical Trial Update: Safety and Tolerability of the Ophthalmic Gel PRO-165 Versus Artelac® Nightime Gel [Phase 1]

View source ↗

Summary

Phase 1 trial comparing safety and tolerability of the ophthalmic gel PRO-165 against Artelac Nighttime Gel in dry eye syndromes; results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dry Eye Syndrome

Drugs mentioned

• Artelac Nighttime Gel
• PRO-165

Snippet

Sponsor: Laboratorios Sophia S.A de C.V. | Conditions: Dry Eye Syndromes | Phase 1 | Status: COMPLETED | Results posted: 2026-01-09